Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders?

John Zhang, John Zhang

Abstract

Background: Poor ovarian response and retrieval of no oocytes following ovarian stimulation for in vitro fertilization (IVF) is a challenging problem for both the patient and the clinician.

Findings: Recent evidence indicates that folliculogenesis occurs in a wave-like fashion indicating that there are multiple follicular recruitment waves in the same menstrual cycle. This relatively new scientific concept provides new opportunities for the utilization of ovarian stimulation in women with poor ovarian response. This communication reports on the social and scientific rationale for the use of luteal phase ovarian stimulation following oocyte retrieval in the same cycle (also called double stimulation).

Conclusions: Data to date showed that double ovarian stimulation in poor responders provides shorter time for retrieving mature oocytes with the potential formation of good quality embryos, and thus healthy pregnancies.

Figures

Fig. 1
Fig. 1
Double ovarian stimulation protocol: both follicular and luteal phase ovarian stimulation in the same cycle. GnRHa, gonadotropin releasing hormone agonist; hCG, human chorionic gonadotropin; FSH, follicle-stimulating hormone; LH, luteinizing hormone

References

    1. van Loendersloot LL, van Wely M, Repping S, Bossuyt PM, van der Veen F. Individualized decision-making in IVF: calculating the chances of pregnancy. Hum Reprod. 2013;28:2972–80. doi: 10.1093/humrep/det315.
    1. Gleicher N, Barad D. “Ovarian age-based” stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization. Fertil Steril. 2006;86:1621–5. doi: 10.1016/j.fertnstert.2006.04.046.
    1. Check JH, Brasile D, Choe JK, Amui J, Wilson C. The effect of cetrorelix vs. ganirelix on pregnancy outcome using minimal gonadotropin stimulation in women with elevated day 3 serum follicle stimulating hormone levels. Clin Exp Obstet Gynecol. 2009;36:148–9.
    1. Lamazou F, Fuchs F, Grynberg M, Gallot V, Herzog E, Fanchin R, et al. Cancellation of IVF-ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations. J Gynecol Obstet Biol Reprod. 2012;41:41–7. doi: 10.1016/j.jgyn.2011.06.001.
    1. Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril. 2003;80:116–22. doi: 10.1016/S0015-0282(03)00544-2.
    1. Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003;69:1023–31. doi: 10.1095/biolreprod.103.017772.
    1. Ben-Shlomo I, Schiff E, Levran D, Ben-Rafael Z, Mashiach S, Dor J. Failure of oocyte retrieval during in vitro fertilization: a sporadic event rather than a syndrome. Fertil Steril. 1991;55:324–7.
    1. Beck-Fruchter R, Weiss A, Lavee M, Geslevich Y, Shalev E. Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Hum Reprod. 2012;27:1357–67. doi: 10.1093/humrep/des037.
    1. Aktas M, Beckers NG, van Inzen WG, Verhoeff A, de Jong D. Oocytes in the empty follicle: a controversial syndrome. Fertil Steril. 2005;84:1643–8. doi: 10.1016/j.fertnstert.2005.05.060.
    1. Bustillo M. Unsuccessful oocyte retrieval: technical artefact or genuine ‘empty follicle syndrome’? Reprod Biomed Online. 2004;8:59–67. doi: 10.1016/S1472-6483(10)60498-1.
    1. Reichman DE, Hornstein MD, Jackson KV, Racowsky C. Empty follicle syndrome--does repeat administration of hCG really work? Fertil Steril. 2010;94:375–7. doi: 10.1016/j.fertnstert.2009.09.040.
    1. Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update. 2012;18:73–91. doi: 10.1093/humupd/dmr039.
    1. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod. 1994;9:188–91.
    1. Yang DZ, Yang W, Li Y, He Z. Progress in understanding human ovarian folliculogenesis and its implications in assisted reproduction. J Assist Reprod Genet. 2013;30:213–9. doi: 10.1007/s10815-013-9944-x.
    1. de Mello Bianchi PH, Serafini P, Monteiro da Rocha A, Assad Hassun P, Alves da Motta EL, Sampaio Baruselli P, et al. Review: follicular waves in the human ovary: a new physiological paradigm for novel ovarian stimulation protocols. Reprod Sci. 2010;17:1067–76. doi: 10.1177/1933719110366483.
    1. Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, et al. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol) Reprod Biomed Online. 2014;29:684–91. doi: 10.1016/j.rbmo.2014.08.009.
    1. Takasaki A, Tamura H, Taketani T, Shimamura K, Morioka H, Sugino N. A pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment. J Ovarian Res. 2013;6:94. doi: 10.1186/1757-2215-6-94.
    1. Reynolds K, Khoury J, Sosnowski J, Thie J, Hofmann G. Comparison of the effect of tamoxifen on endometrial thickness in women with thin endometrium (<7 mm) undergoing ovulation induction with clomiphene citrate. Fertil Steril. 2010;93:2091–3. doi: 10.1016/j.fertnstert.2009.08.038.
    1. Kato K, Takehara Y, Segawa T, Kawachiya S, Okuno T, Kobayashi T, et al. Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort. Reprod Biol Endocrinol. 2012;10:35. doi: 10.1186/1477-7827-10-35.
    1. Rombauts L, Suikkari AM, MacLachlan V, Trounson AO, Healy DL. Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril. 1998;69:665–9. doi: 10.1016/S0015-0282(98)00018-1.
    1. Kansal Kalra S, Ratcliffe S, Gracia CR, Martino L, Coutifaris C, Barnhart KT. Randomized controlled pilot trial of luteal phase recombinant FSH stimulation in poor responders. Reprod Biomed Online. 2008;17:745–50. doi: 10.1016/S1472-6483(10)60400-2.

Source: PubMed

Подписаться